These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 16142672
21. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease. Jhun BW, Kim SY, Moon SM, Jeon K, Kwon OJ, Huh HJ, Ki CS, Lee NY, Shin SJ, Daley CL, Koh WJ. Am J Respir Crit Care Med; 2018 Nov 15; 198(10):1322-1330. PubMed ID: 29877739 [Abstract] [Full Text] [Related]
22. Prolonged fever due to Mycobacterium avium complex (MAC) disease in advanced HIV infection: a public health concern. Suwanagool S, Kolladarungkri T, Leelarasamee A, Chuenarom V, Jearanaisilavong J, Chaiprasert A. J Med Assoc Thai; 1998 Nov 15; 81(11):893-905. PubMed ID: 9803090 [Abstract] [Full Text] [Related]
26. Monotherapy: Key cause of macrolide-resistant Mycobacterium avium complex disease. Loewenstein D, van Balveren L, Lemson A, Hanemaaijer N, Hoefsloot W, van Ingen J. Respir Med; 2023 Oct 15; 217():107366. PubMed ID: 37481170 [Abstract] [Full Text] [Related]
32. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy. Ito Y, Miwa S, Shirai M, Kanai M, Fujita K, Ohba H, Iwaizumi E, Oshima T, Kojima S, Suda T, Hayakawa H. Respir Med; 2020 Aug 01; 169():106025. PubMed ID: 32442113 [Abstract] [Full Text] [Related]
33. The recovery of Mycobacterium avium-intracellulare complex (MAC) from the residential bathrooms of patients with pulmonary MAC. Nishiuchi Y, Maekura R, Kitada S, Tamaru A, Taguri T, Kira Y, Hiraga T, Hirotani A, Yoshimura K, Miki M, Ito M. Clin Infect Dis; 2007 Aug 01; 45(3):347-51. PubMed ID: 17599313 [Abstract] [Full Text] [Related]
36. Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. Davis KK, Kao PN, Jacobs SS, Ruoss SJ. BMC Pulm Med; 2007 Feb 23; 7():2. PubMed ID: 17319962 [Abstract] [Full Text] [Related]
37. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease. Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS. J Infect Dis; 2003 Jun 15; 187(12):1977-80. PubMed ID: 12792877 [Abstract] [Full Text] [Related]
38. Case report. Diagnosis of disseminated Mycobacterium avium complex infection by liver biopsy. Shah SR, Rastegar DA, Nicol TL. AIDS Read; 2000 Nov 15; 10(11):669-72. PubMed ID: 11186192 [Abstract] [Full Text] [Related]
39. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG. J Antimicrob Chemother; 2007 Oct 15; 60(4):733-40. PubMed ID: 17673477 [Abstract] [Full Text] [Related]
40. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M, Shirakawa T. Kekkaku; 2005 Sep 15; 80(9):613-29. PubMed ID: 16245793 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]